Literature DB >> 17056321

Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE).

Pierluigi Tricoci1, Eric D Peterson, Jyotsna Mulgund, L Kristin Newby, Jorge F Saucedo, Neil S Kleiman, Deepak L Bhatt, Peter B Berger, Christopher P Cannon, David J Cohen, Judith S Hochman, E Magnus Ohman, W Brian Gibler, Robert A Harrington, Sidney C Smith, Matthew T Roe.   

Abstract

We evaluated temporal trends in the use of early (<48 hours) catheterization in patients with non-ST-segment elevation acute coronary syndromes with respect to baseline risk features since publication of the American College of Cardiology/American Heart Association guidelines, which include a class IA recommendation for an early invasive strategy for high-risk patients with non-ST-segment elevation acute coronary syndromes. Overall, we found that early catheterization use increased from 53% to 61% during the 3 years after the guidelines were released, but the increased use of early catheterization was highest (11%) in the group that was at lowest risk of predicted mortality, and it was lowest (6%) in the group at highest risk of predicted mortality who would potentially receive the most benefit from an aggressive treatment approach. In conclusion, despite the overall increase in the use of early catheterization, the gap between the use of an early invasive strategy in the highest and lowest risk patients remains large and tends to increase over time.

Entities:  

Mesh:

Year:  2006        PMID: 17056321     DOI: 10.1016/j.amjcard.2006.05.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice.

Authors:  Angela S Koh; Stanley Chia; Tan Jkb; Siti M Zaini; Guo Kwq; Yeo Kk; Chua Tsj; Tian Hai Koh; Jack W C Tan
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

2.  Do imaging studies performed in physician offices increase downstream utilization?: an empiric analysis of cardiac stress testing with imaging.

Authors:  Jersey Chen; Reza Fazel; Joseph S Ross; Robert L McNamara; Andrew J Einstein; Mouaz Al-Mallah; Harlan M Krumholz; Brahmajee K Nallamothu
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

Review 3.  Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification.

Authors:  Henry Chang; James K Min; Sunil V Rao; Manesh R Patel; Orlando P Simonetti; Giuseppe Ambrosio; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2012-07       Impact factor: 7.792

4.  Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome.

Authors:  Juan Sanchis; Julio Núñez; Vicente Bodí; Eduardo Núñez; Ana García-Alvarez; Clara Bonanad; Ander Regueiro; Xavier Bosch; Magda Heras; Joan Sala; Oscar Bielsa; Angel Llácer
Journal:  Mayo Clin Proc       Date:  2011-02-23       Impact factor: 7.616

5.  Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Robert Giugliano; Christopher B Granger; Kenneth W Mahaffey; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa-Filho; Marcia M Barbosa; Maria da Consolacao V Moreira; Renato A K Kalil; Marildes Freitas; Joao Carlos de Campos Guerra; Marcio Vinicius Lins Barros; Thiago da Rocha Rodrigues; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

6.  Lessons learned from the CRUSADE National Quality Improvement Initiative.

Authors:  Eric D Peterson; David Z Bynum; Matthew T Roe
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

Review 7.  Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX).

Authors:  Marcello Marino; Diego Rizzotti; Sergio Leonardi
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

8.  [Timing of invasive treatment in NSTEMI: as fast as in STEMI?].

Authors:  A Jobs; I Eitel; S Desch
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

9.  Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.

Authors:  Bernardo Lombo; José G Díez
Journal:  Core Evid       Date:  2011-03-17

10.  Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners' perceptions.

Authors:  Josien Engel; Marie-Julie Heeren; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2014-09-22       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.